Annual Information Update

RNS Number : 8406Z

Dechra Pharmaceuticals PLC

29 September 2009

 



Issued by Citigate Dewe Rogerson Limited, Birmingham

Date: 29 September 2009

Dechra® Pharmaceuticals PLC

(the 'Company' or the 'Group')

Annual Information Update

Annual Information Update for the 12 months up to and including 29 September 2009 the Company provides the following information update in accordance with Prospectus Rule 5.2.

1.    RNS Announcements

Further details on the information contained within the RNS announcements listed below can be viewed on the London Stock Exchange website: www.londonstockexchange.com (under code: DPH.) and also on the Company Website: www.dechra.com

Date of Announcement	RNS Headline
25 September 2009	Director/PDMR Shareholding
21 September 2009	Blocklisting
18 September 2009	Annual Report & Accounts
15 September 2009	Blocklisting Interim Review
15 September 2009	Blocklisting Interim Review
15 September 2009	Blocklisting Interim Review
04 September 2009	Holding(s) in Company
01 September 2009	Preliminary Results
19 August 2009	Notice of Results
10 August 2009	Holding(s) in Company
04 August 2009	Holding(s) in Company
15 July 2009	Holding(s) in Company
07 July 2009	Trading Update
30 June 2009	Total Voting Rights
29 June 2009	Director/PDMR Shareholding
25 June 2009	Director/PDMR Shareholding
17 June 2009	Holding(s) in Company
04 June 2009	Holding(s) in Company
03 June 2009	Product Development Update
29 May 2009	Total Voting Rights
20 May 2009	Director/PDMR Shareholding
06 May 2009	Holding(s) in Company
05 May 2009	Holding(s) in Company
30 April 2009	Total Voting Rights
28 April 2009	Interim Management Statement
23 April 2009	Appointment of Adviser and Broker
17 April 2009	Holding(s) in Company
01 April 2009	Additional Listing
31 March 2009	Holding(s) in Company
31 March 2009	Total Voting Rights
27 March 2009	In-License Technology Agreement
26 March 2009	Holding(s) in Company
25 March 2009	Holding(s) in Company
23 March 2009	Holding(s) in Company
18 March 2009	Director Declaration
16 March 2009	Blocklisting Interim Review
16 March 2009	Blocklisting Interim Review
16 March 2009	Blocklisting Interim Review
16 March 2009	Blocklisting Interim Review
10 March 2009	Document on View
05 March 2009	Holding(s) in Company
03 March 2009	Holding(s) in Company
27 February 2009	Total Voting Rights 'Replacement'
26 February 2009	Director Declaration
24 February 2009	Holding(s) in Company
24 February 2009	Half Yearly Report
05 February 2009	Holding(s) in Company
04 February 2009	Holding(s) in Company
02 February 2009	Notice of Results
29 January 2009	Holding(s) in Company
26 January 2009	Holding(s) in Company
23 January 2009	Holding(s) in Company
22 January 2009	Holding(s) in Company
20 January 2009	Holding(s) in Company
14 January 2009	Holding(s) in Company
12 January 2009	Pre-Closed Period Trading Update
09 January 2009	Director/PDMR Shareholding
07 January 2009	Holding(s) in Company
31 December 2008	Total Voting Rights
15 December 2008	Vetoryl Receives Full FDA Approval
10 December 2008	Director/PDMR Shareholding
01 December 2008	Director/PDMR Shareholding
20 November 2008	Director/PDMR Shareholding
7 November 2008	Result of AGM
7 November 2008	Interim Management Statement
31 October 2008	Total Voting Rights
24 October 2008	Holding(s) in Company
22 October 2008	Director PDMR/Shareholding
20 October 2008	Director PDMR/Shareholding
16 October 2008	Director PDMR/Shareholding
14 October 2008	Director PDMR/Shareholding
30 September 2008	Total Voting Rights
23 September 2008	Annual Information Update

2.    Documents filed at Companies House

All of the documents listed below were filed with the Registrar of Companies in England and Wales.

Copies of all documents filed with the Registrar of Companies can be obtained from Companies House, Crown Way, Cardiff CF14 3UZ or through the website www.companieshouse.gov.uk.

17 July 2009	Form 88(2) - allotment of shares
17 July 2009	Form 88(2) - allotment of shares
01 June 2009	Form 363(a) - annual return
17 April 2009	Form 88(2) - allotment of shares
17 April 2009	Form 88(2) - allotment of shares
21 January 2009	Form 88(2) - allotment of shares
5 December 2008	Form 288(c) - secretaries particulars changed
13 November 2008	Special Resolution passed at the AGM
11 November 2008	Accounts for the year ended June 2008
20 October 2008	Form 88(2) - allotment of shares
20 October 2008	Form 88(2) - allotment of shares
20 October 2008	Form 88(2) - allotment of shares

3.    Documents published or sent to Shareholders

The Company's Annual Report for the year ended 30 June 2009 (which was filed with the UKLA Document Viewing Facility on 18 September 2009) can be found on the Company website (www.dechra.com), as can the Half-Year Report 2008 published in February 2009.

In accordance with Prospectus Rule 5.2.7, we confirm that to the best of our knowledge, the information relating to the Company referred to above is up to date at the date of the announcement but it is acknowledged that such disclosures may, at any time, become out of date, due to changing circumstances.

A copy of this Annual Information Update and copies of the documents referred to in it can be obtained from the Company Secretary at the Company's registered office:

Dechra House

Jamage Industrial Estate

Talke Pits

Stoke on Trent

ST7 1XW

Enquiries:

Zoe Goulding

Company Secretary

Dechra Pharmaceuticals PLC

Tel: [phone]

Trademarks appear throughout this release in italics.  Dechra and the Dechra 'D' logo are registered Trademarks of Dechra Pharmaceuticals PLC

 

END

 

 

AIUUKUKRKRRKURR